#Dr. #Manuel #Cervantes #Ocampo, coordinator of comprehensive health care at the first level of the IMSS, reported that a worker from the institution presented a strong adverse reaction from the COVID-19 vaccine.
#In a press conference held this #Wednesday, the official indicated that the worker required the application of an antihistamine, as well as a medication to remove the allergy that was causing it.
“#In the case of our colleague, who I cannot give more information due to confidentiality, she presented an intense headache, dizziness and difficulty in breathing and passing food. #This was an expected event which was handled in a timely manner,” he said.
“#We remember that in each vaccination center there is a waiting room where we are waiting for them 30 minutes before they go back to their homes or their work. #Our coworker presented these events 4 hours later, which were handled promptly.”
#Cervantes indicated that, in addition to this event, among the 7,728 people IMSS workers who have already been vaccinated have presented themselves 22 cases of vaccine reactions, which have been mild.
#However, the official stressed that this type of event is expected whenever a vaccine is applied.
“#As expected, and this is very important, there have been some events attributable to vaccination. #Mild, 22 cases of which I have just commented, one grave that only required the application of an antihistamine, a medicine to remove the allergy that was causing it, without any problem at the moment. “
“They are events attributable to vaccination that are expected, such as headache, dizziness, some palpitations that have been treated in a very timely manner.”
#So far, #Pfizer’s vaccine is the only one that has been implemented in #Mexico.
#You may also like:
#Argentina, the first country in #Latin #America to authorize the use of the #Oxford-AstraZeneca vaccine
#Sheinbaum promises criminal sanctions to those who seek to ‘skip’ the vaccination line in CDMX
[ source link ]
##Female #worker #presents #strong #reaction #vaccine #COVID #medicine #problem #IMSS